Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children

NCT07320716 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

528

Enrollment

INDUSTRY

Sponsor class

Conditions

Diarrhoea

Interventions

BIOLOGICAL: AltSonflex1-2-3
BIOLOGICAL: Menveo
BIOLOGICAL: Infanrix hexa
BIOLOGICAL: TYPHIBEV

Sponsor

GlaxoSmithKline